Elaine R. Mardis, PhD
The American Association for Cancer Research (AACR) inaugurated Elaine R. Mardis, PhD, as President for 2019–2020 during the 2019 AACR Annual Meeting. Dr. Mardis holds the Nationwide Foundation Endowed Chair in Genomic Medicine and is Co–Executive Director of the Institute for Genomic Medicine at Nationwide Children’s Hospital in Columbus, Ohio. She also is Professor of Pediatrics at The Ohio State University College of Medicine.
Also at the meeting, Antoni Ribas, MD, PhD, Professor of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles, was inducted as President-Elect. Elizabeth M. Jaffee, MD, Deputy Director for the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and Associate Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy, now serves as Past President.
DR. MARDIS’ RESEARCH centers on the genomic characterization of cancer and its implications for precision cancer medicine. She has presented keynote addresses and other invited remarks at international conferences on topics such as cancer genomics, next-generation sequencing technology, personalized medicine, and cancer immunogenomics.
A member of the AACR since 2009, Dr. Mardis is currently serving as an AACR Project GENIE Advisory Board member, an AACR Special Conferences committee member, and Senior Editor of the AACR journal Molecular Cancer Research. She previously served on the Board of Directors, as Chair of the AACR Annual Meeting 2018 Program Committee, as a committee member for the Pezcoller Foundation–AACR Award, and as a member of the Steering Committee for the AACR Cancer Progress Report 2014. In addition, she was Co-Chair of the AACR Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy conference in Salt Lake City.
Dr. Mardis was recently elected to the 2019 class of Fellows of the AACR Academy, received the Precision Medicine World Congress 2017 Luminary Award, the American Association for Clinical Chemistry Morton K. Schwartz Award for Significant Contributions in Cancer Research Diagnostics, and the Scripps Research Institute Translational Medicine Award. ■